BioCentury
ARTICLE | Clinical News

Fibrostat topical transglutaminase inhibitor cream regulatory update

September 25, 2000 7:00 AM UTC

The University of Manitoba (Winnipeg, Manitoba) received a Canadian patent covering the use of transglutaminase inhibitors to treat scars resulting from surgery or burns. PBP is the exclusive licensee...